AI Article Synopsis
- Synovial sarcoma is a rare and challenging tumor that requires innovative treatment strategies.
- A 46-year-old woman with a specific type of this tumor in her thigh opted for two courses of Boron Neutron Capture Therapy (BNCT) instead of surgery, leading to significant tumor reduction.
- After BNCT, the tumor was completely removed, and the patient can now walk independently without any recurrence, suggesting that BNCT could be a promising adjuvant therapy for this condition, though more research is necessary to solidify its effectiveness.
Article Abstract
Synovial sarcoma is a rare tumor requiring new treatment methods. A 46-year-old woman with primary monophasic synovial sarcoma in the left thigh involving the sciatic nerve, declining surgery because of potential dysfunction of the affected limbs, received two courses of BNCT. The tumor thus reduced was completely resected with no subsequent recurrence. The patient is now able to walk unassisted, and no local recurrence has been observed, demonstrating the applicability of BNCT as adjuvant therapy for synovial sarcoma. Further study and analysis with more experience accumulation are needed to confirm the real impact of BNCT efficacy for its application to synovial sarcoma.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.apradiso.2020.109407 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!